KBMED Expands Its Presence in South Asia: Combined Epidural & Spinal Kit Receives Bangladesh DGDA Registration

KBMED is pleased to announce that its Combined Epidural & Spinal Kit (CSE Kit) has officially received registration approval from the Directorate General of Drug Administration (DGDA) of Bangladesh. This achievement follows the successful registration of KBMED's Epidural Kit, marking another important milestone in the company's growing Anesthesia & Pain Management portfolio.

Expanding Pain Management Solutions in Bangladesh

As one of South Asia's emerging healthcare markets, Bangladesh continues to experience growing demand for reliable, cost-effective anesthesia products. With the addition of the Combined Epidural & Spinal Kit, KBMED further strengthens its product offering, providing healthcare professionals with more comprehensive regional anesthesia solutions.

Advanced CSE Technology for Enhanced Clinical Performance

The Combined Epidural & Spinal Kit combines the benefits of spinal and epidural anesthesia in a single procedure, enabling rapid onset of analgesia while maintaining extended pain control. Designed with a specialized needle-through-needle technique, the system supports precise placement, procedural efficiency, and improved patient outcomes across a wide range of surgical and obstetric applications.

Supporting Healthcare Growth in South Asia

"Bangladesh remains one of our strategic markets in South Asia," said Ruffy. L, a manager from KBMED's International Business Division. "With both the Epidural Kit and Combined Epidural & Spinal Kit now registered, we are committed to supporting hospitals and healthcare providers with high-quality pain management solutions, reliable supply, and professional technical support."

The latest approval reinforces KBMED's long-term commitment to expanding access to innovative anesthesia and pain management products worldwide while supporting better patient care across the region.